Slideshow
Author(s):
Pain related to more severe motor symptoms, phosphodiesterase 10A loss seen early, novel therapy shows promise, and other recent findings are summarized here.
Medtronics’ BrainSense Adaptive DBS and Electrode Identifier Gain CE Mark Approval for Parkinson Disease
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
NeuroVoices: Nigel Bunnett, PhD, BSc, on Identifying a Novel Therapeutic Target for Chronic Pain
Neurology Unwrapped: 2024’s Most Intriguing Conversations
FDA Action Update, December 2025: Approval, Designations, and Clinical Hold
NeurologyLive® Year in Review 2024: Most-Watched Video Series